Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neurologic Manifestations of Chronic Methamphetamine Abuse</title><author><name sortKey="Rusyniak, Daniel E" sort="Rusyniak, Daniel E" uniqKey="Rusyniak D" first="Daniel E." last="Rusyniak">Daniel E. Rusyniak</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23688691</idno><idno type="pmc">3764482</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764482</idno><idno type="RBID">PMC:3764482</idno><idno type="doi">10.1016/j.psc.2013.02.005</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">000260</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000260</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Neurologic Manifestations of Chronic Methamphetamine Abuse</title><author><name sortKey="Rusyniak, Daniel E" sort="Rusyniak, Daniel E" uniqKey="Rusyniak D" first="Daniel E." last="Rusyniak">Daniel E. Rusyniak</name></author></analytic><series><title level="j">The Psychiatric clinics of North America</title><idno type="ISSN">0193-953X</idno><idno type="eISSN">1558-3147</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>COMMENTARY ON METHAMPHETAMINE ABUSE FOR PSYCHIATRIC PRACTICE</title><p id="P1">Every decade seems to have its own unique drug problem. The 1970s had hallucinogens, the 1980s had crack cocaine, the 1990s had designer drugs, the 2000s had methamphetamine (Meth), and in the 2010s we are dealing with the scourge of prescription drug abuse. While each of these drug epidemics has distinctive problems and history, the one with perhaps the greatest impact on the practice of Psychiatry is Meth. By increasing the extracellular concentrations of dopamine while slowly damaging the dopaminergic neurotransmission, Meth is a powerfully addictive drug whose chronic use preferentially causes psychiatric complications. Chronic Meth users have deficits in memory and executive functioning as well as higher rates of anxiety, depression, and most notably psychosis. It is because of addiction and chronic psychosis from Meth abuse that the Meth user is most likely to come to the attention of the practicing Psychiatrist/Psychologist.</p><p id="P2">Understanding the chronic neurologic manifestations of Meth abuse will better arm practitioners with the diagnostic and therapeutic tools needed to make the Meth epidemic one of historical interest only.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">7708110</journal-id><journal-id journal-id-type="pubmed-jr-id">6531</journal-id><journal-id journal-id-type="nlm-ta">Psychiatr Clin North Am</journal-id><journal-id journal-id-type="iso-abbrev">Psychiatr. Clin. North Am.</journal-id><journal-title-group><journal-title>The Psychiatric clinics of North America</journal-title></journal-title-group><issn pub-type="ppub">0193-953X</issn><issn pub-type="epub">1558-3147</issn></journal-meta><article-meta><article-id pub-id-type="pmid">23688691</article-id><article-id pub-id-type="pmc">3764482</article-id><article-id pub-id-type="doi">10.1016/j.psc.2013.02.005</article-id><article-id pub-id-type="manuscript">NIHMS467929</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Neurologic Manifestations of Chronic Methamphetamine Abuse</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rusyniak</surname><given-names>Daniel E.</given-names></name><degrees>MD</degrees><aff id="A1">Department of Emergency Medicine, Indiana University School of Medicine, 1050 Wishard Boulevard, Room 2200, Indianapolis, IN 46202, USA,<email>drusynia@iupui.edu</email></aff></contrib></contrib-group><pub-date pub-type="nihms-submitted"><day>26</day><month>8</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>11</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>6</month><year>2014</year></pub-date><volume>36</volume><issue>2</issue><fpage>261</fpage><lpage>275</lpage><permissions><copyright-statement>© 2013 Elsevier Inc. All rights reserved.</copyright-statement><copyright-year>2013</copyright-year></permissions><abstract><title>COMMENTARY ON METHAMPHETAMINE ABUSE FOR PSYCHIATRIC PRACTICE</title><p id="P1">Every decade seems to have its own unique drug problem. The 1970s had hallucinogens, the 1980s had crack cocaine, the 1990s had designer drugs, the 2000s had methamphetamine (Meth), and in the 2010s we are dealing with the scourge of prescription drug abuse. While each of these drug epidemics has distinctive problems and history, the one with perhaps the greatest impact on the practice of Psychiatry is Meth. By increasing the extracellular concentrations of dopamine while slowly damaging the dopaminergic neurotransmission, Meth is a powerfully addictive drug whose chronic use preferentially causes psychiatric complications. Chronic Meth users have deficits in memory and executive functioning as well as higher rates of anxiety, depression, and most notably psychosis. It is because of addiction and chronic psychosis from Meth abuse that the Meth user is most likely to come to the attention of the practicing Psychiatrist/Psychologist.</p><p id="P2">Understanding the chronic neurologic manifestations of Meth abuse will better arm practitioners with the diagnostic and therapeutic tools needed to make the Meth epidemic one of historical interest only.</p></abstract><kwd-group><kwd>Methamphetamine abuse</kwd><kwd>Psychosis</kwd><kwd>Parkinson’s</kwd><kwd>Choreoathetoid</kwd><kwd>Punding</kwd><kwd>Formication</kwd></kwd-group><funding-group><award-group><funding-source country="United States">National Institute on Drug Abuse : NIDA</funding-source><award-id>R01 DA026867 || DA</award-id></award-group></funding-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000260 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000260 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= DanceTherParkinsonV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.35. |  |